Last deal

Amount

Grant

Stage

06.06.2023

Date

1

all rounds

General

About Company
Proteologix develops robust technology for drugs targeting autoimmune diseases and oncology.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Proteologix US

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Proteologix is a biotech company that develops drugs using robust technology targeting autoimmune/inflammatory diseases and oncology patients.
Contacts